Industry Insights: Healthcare. The latest healthcare industry insights distilled

Industry Insights: Healthcare 16th May

Industry Insights: Healthcare 16th May

  • Reading time:2 mins read

Industry Insights Healthcare: 16/05/25

In this week’s insights post, we elaborate on three of the most recent developments in the healthcare industry.

 

Trump executive order aims to reduce US drug prices by 59%

On 12 May 2025, US President Donald J. Trump signed an executive order to reduce prescription drug prices for American patients. The so-called most-favored-nation policy aims to align US pharmaceutical costs with those in other developed nations. According to Trump, this initiative will lower prescription drug pricing in the US by 59%. This move builds upon previous efforts by the Trump administration to address high drug prices and improve healthcare services. The administration emphasised that the order is part of a strategy to put American patients first by ensuring fair pricing and preventing the foreign exploitation of American pharmaceutical innovation.

Link to press release

 

Updated guidelines aim to improve GORD diagnosis and treatment

The American College of Gastroenterology (ACG) has released revised guidelines for the diagnosis and management of gastro-oesophageal reflux disease (GORD or GERD). GORD remains one of the most common digestive conditions worldwide. The updated guidance defined a more precise, evidence-based approach to diagnosing GORD, particularly in distinguishing it from other causes of heartburn. The guidance advised against the overuse of proton pump inhibitors (PPIs), advocating for more diagnostic testing before treatment. It also recommended specific lifestyle modifications, such as weight loss and dietary modifications.

Link to the guidance

 

Five facts you should know about skin cancer

A recent overview from the American Journal of Managed Care (AJMC) acknowledged May as the National Skin Cancer Detection and Awareness Month by publishing five must-know facts about skin cancer

First, skin cancer is the most common type of cancer globally; its rates are rising, particularly among young people and those with high sun exposure. Second, early detection markedly improves outcomes: melanoma survival rates exceed 99% if caught early. Third, some skin cancers, including non-melanoma types, can be locally destructive and return if not treated properly. Fourth, regular use of sunscreen and protective clothing remains the most effective skin cancer prevention strategy. Finally, those with a history of skin cancer are at an increased risk of developing new lesions, highlighting the need for ongoing monitoring. 

Link to the full article

 

Want to get in touch? Contact us at https://elion.nz/get-in-touch/

Elion Medical Communications